AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

QUETIAPINE 25 Mg ;

12 registrations across 1 African market— 12 active

Markets with QUETIAPINE 25 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Psyquel 25mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Quedress 25 mg
Film Coated Tablets
🇪🇬EgyptPharmacredoactive
Quebolm 25 mg
Film Coated Tablets
🇪🇬EgyptMedisave Developedactive
Quitiadel 25 mg
Film Coated Tablets
🇪🇬EgyptElixir pharmaactive
Quetiasu 25 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Psyquel 25mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Spiraquet 25mg
Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Quedress 25 mg
Film Coated Tablets
🇪🇬EgyptPharmacredoactive
Quebolm 25 mg
Film Coated Tablets
🇪🇬EgyptMedisave Developedactive
Spiraquet 25mg
Film Coated Tablets
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Quitiadel 25 mg
Film Coated Tablets
🇪🇬EgyptElixir pharmaactive
Quetiasu 25 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive

QUETIAPINE 25 Mg ; in Africa — Regulatory Overview

QUETIAPINE 25 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.